Solutions
One site network. Meet participants where they are.
Lightship executes studies across in‑clinic, hybrid, virtual, and MRU settings, matching each visit to what the protocol requires. Investigators, coordinators, and nurses work from one quality and oversight framework regardless of setting — so standards stay consistent whether a visit happens at a physical site, in a participant’s home, or through telemedicine.
From physical sites and investigators with multi‑state licensure, the network reaches participants across all 50 states — without asking sponsors to piece together separate vendors for each setting.
Site coverage allows for access to participants typically within ~30 miles of the site. Visits happen in‑clinic, with the full team, equipment, and oversight already in place.
Best for protocols that require complex procedures, specialized equipment, or in‑person assessments that need to stay anchored to a clinic.
Reduces travel burden with at‑home and telemedicine touchpoints, typically extending geographic reach by ~60%.
Best for protocols where some visits anchor in‑clinic and others can move into the home or virtual settings to reduce participant burden.
Allows for national coverage, with visits conducted at home or via telemedicine and remote oversight from PIs/Sub‑Is with multi-state licensure.
Best for protocols where visits can safely occur outside a clinical setting.
As a national screening site, we provide centralized consent, labs, and eligibility review for programs with high screening volume or lab‑driven eligibility criteria.
Lightship’s investigators bring experience across a variety of therapeutic areas, from Neurology to Allergy & Immunology to Women’s Health. Multi‑state licensure lets that expertise extend into communities a single‑site model can’t reach — so specialized care follows the participant instead of stopping at the clinic door.
From early planning through close-out, Lightship offers a strategic, coordinated path that supports protocol, accelerates activation, and delivers studies with consistency across settings.
Align early on visit placement and participant experience to support study timelines.
2x
Enrollment rate
As little as
For study startup
Average
95%
.
40%+
2.5x
Quality doesn’t shift by setting. More than 30 sponsor audits completed with zero critical findings. Lightship has engaged the FDA twice, receiving supportive feedback on its hybrid and MRU ‑based delivery model. The same oversight and quality frameworks apply whether the visit happens at a site in Texas or a participant’s living room in Massachusetts.
That same consistency extends to data. Lightship integrates with the platforms and workflows sponsors already use, rather than requiring adoption of new systems, so oversight carries through without adding another system for study teams to manage.
